{"id":"https://openalex.org/W7225835006","doi":"https://doi.org/10.1007/s00277-026-07350-0","title":"Updated analysis of overall survival with imetelstat in relapsed/refractory myelofibrosis versus real-world data, and assessment of real-world treatment patterns","display_name":"Updated analysis of overall survival with imetelstat in relapsed/refractory myelofibrosis versus real-world data, and assessment of real-world treatment patterns","publication_year":2026,"publication_date":"2026-11-11","ids":{"openalex":"https://openalex.org/W7225835006","doi":"https://doi.org/10.1007/s00277-026-07350-0"},"language":"en","primary_location":{"id":"doi:10.1007/s00277-026-07350-0","doi":"https://doi.org/10.1007/s00277-026-07350-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00277-026-07350-0","pdf_url":null,"source":{"id":"https://openalex.org/S163204731","display_name":"Annals of Hematology","issn_l":"0939-5555","issn":["0939-5555","1432-0584"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Hematology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1007/s00277-026-07350-0","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047764826","display_name":"Andrew Tucker Kuykendall","orcid":"https://orcid.org/0000-0002-9040-7415","observed_orcids":["https://orcid.org/0000-0002-9040-7415"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Andrew T. Kuykendall","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009653670","display_name":"Hana Qasim","orcid":"https://orcid.org/0000-0002-9354-6314","observed_orcids":["https://orcid.org/0000-0002-9354-6314"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hana Qasim","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075099165","display_name":"Ghada Araji","orcid":"https://orcid.org/0000-0001-5339-3010","observed_orcids":["https://orcid.org/0000-0001-5339-3010"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ghada Araji","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148632394","display_name":"Libo Sun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114060","display_name":"Geron (United States)","ror":"https://ror.org/026vpvt76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114060"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Libo Sun","raw_affiliation_strings":["Geron Corporation, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geron Corporation, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210114060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109737956","display_name":"Qi Xia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114060","display_name":"Geron (United States)","ror":"https://ror.org/026vpvt76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114060"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qi Xia","raw_affiliation_strings":["Geron Corporation, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geron Corporation, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210114060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117727989","display_name":"Michelle Mudge-Riley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114060","display_name":"Geron (United States)","ror":"https://ror.org/026vpvt76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114060"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle Mudge-Riley","raw_affiliation_strings":["Geron Corporation, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geron Corporation, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210114060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064593754","display_name":"Joseph Eid","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114060","display_name":"Geron (United States)","ror":"https://ror.org/026vpvt76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114060"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Eid","raw_affiliation_strings":["Geron Corporation, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geron Corporation, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210114060"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010075752","display_name":"Rami S. Komrokji","orcid":"https://orcid.org/0000-0002-1876-5269","observed_orcids":["https://orcid.org/0000-0002-1876-5269"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rami S. Komrokji","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5047764826"],"corresponding_institution_ids":["https://openalex.org/I3019308854"],"apc_list":{"value":4590,"currency":"USD","value_usd":4590},"apc_paid":{"value":4590,"currency":"USD","value_usd":4590},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.9769999980926514},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.8996999859809875},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8848999738693237},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7384999990463257},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.6620000004768372},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.6208999752998352},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5741999745368958},{"id":"https://openalex.org/C194409129","wikidata":"https://www.wikidata.org/wiki/Q103824","display_name":"Hematology","level":2,"score":0.5658000111579895},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5037999749183655},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.4083999991416931},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4011000096797943},{"id":"https://openalex.org/C2776233030","wikidata":"https://www.wikidata.org/wiki/Q17149812","display_name":"Janus kinase inhibitor","level":4,"score":0.38940000534057617},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.3799000084400177},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.3720000088214874},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.34299999475479126},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.31450000405311584},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3118000030517578},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.30959999561309814},{"id":"https://openalex.org/C112392421","wikidata":"https://www.wikidata.org/wiki/Q903451","display_name":"Janus kinase","level":3,"score":0.3091999888420105},{"id":"https://openalex.org/C2781107747","wikidata":"https://www.wikidata.org/wiki/Q1898104","display_name":"Myeloproliferative neoplasm","level":4,"score":0.29429998993873596},{"id":"https://openalex.org/C17923572","wikidata":"https://www.wikidata.org/wiki/Q7250160","display_name":"Propensity score matching","level":2,"score":0.29339998960494995},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.2793000042438507},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.27399998903274536},{"id":"https://openalex.org/C32465701","wikidata":"https://www.wikidata.org/wiki/Q14914514","display_name":"Janus kinase 2","level":3,"score":0.25279998779296875}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1007/s00277-026-07350-0","doi":"https://doi.org/10.1007/s00277-026-07350-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00277-026-07350-0","pdf_url":null,"source":{"id":"https://openalex.org/S163204731","display_name":"Annals of Hematology","issn_l":"0939-5555","issn":["0939-5555","1432-0584"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Hematology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1007/s00277-026-07350-0","doi":"https://doi.org/10.1007/s00277-026-07350-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00277-026-07350-0","pdf_url":null,"source":{"id":"https://openalex.org/S163204731","display_name":"Annals of Hematology","issn_l":"0939-5555","issn":["0939-5555","1432-0584"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Hematology","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"In":[0,174],"a":[1,32,63],"previous":[2],"analysis":[3,58,143],"of":[4,178],"the":[5,47,114,140,175,226],"phase":[6],"2":[7],"IMbark":[8,60,145,192],"trial,":[9],"imetelstat":[10,149,190],"showed":[11,110],"significantly":[12],"longer":[13,132,185],"median":[14,165],"overall":[15],"survival":[16,142],"(mOS)":[17],"in":[18,31,73,113,122,191,220],"patients":[19,61,85,104,146,157,179,187,224],"with":[20,39,62,148,159,189,197,210],"Janus":[21],"kinase":[22],"inhibitor":[23],"relapsed/refractory":[24],"(R/R)":[25],"intermediate-2\u2013risk":[26],"or":[27,244],"high-risk":[28],"myelofibrosis":[29,49],"than":[30,134,193],"closely":[33],"matched":[34,155],"real-world":[35],"(RW)":[36],"cohort":[37,66],"treated":[38,147,158,188,196],"best":[40],"available":[41],"therapy":[42],"(BAT)":[43],"after":[44,67,128,213],"ruxolitinib.":[45],"Because":[46],"evolving":[48],"treatment":[50,75,101,124,248],"landscape":[51],"may":[52,229],"influence":[53],"outcomes,":[54],"an":[55],"updated":[56,141],"OS":[57,183,221],"compared":[59],"larger":[64],"RW":[65,74,81,156,223],"extended":[68],"follow-up":[69,166],"and":[70,93,98,108,121,154,170,238],"explored":[71],"changes":[72],"patterns":[76,102,249],"over":[77,225],"this":[78],"period.":[79],"The":[80,217],"dataset":[82],"included":[83],"126":[84],"at":[86],"Moffitt":[87],"Cancer":[88],"Center":[89],"who":[90],"discontinued":[91],"ruxolitinib":[92,119,123,236],"received":[94],"BAT":[95,160,198],"between":[96,144],"2010":[97],"2025.":[99],"Comparing":[100],"for":[103],"diagnosed":[105,127,136,180],"before/after":[106],"2016":[107],"2019":[109],"significant":[111,218],"reductions":[112],"time":[115,234],"from":[116],"diagnosis":[117],"to":[118,232,235,241],"initiation":[120,237],"duration.":[125],"Patients":[126],"2016/2019":[129],"had":[130],"notably":[131],"mOS":[133],"those":[135,195],"before":[137,181],"2016/2019.":[138],"For":[139],"(":[150,161],"n":[151,162],"=":[152,163,206],"59)":[153],"54),":[164],"periods":[167],"were":[168],"46.2":[169],"48.2":[171],"months,":[172],"respectively.":[173],"historical":[176],"comparison":[177],"2016,":[182],"was":[184],"among":[186,194,222],"(mOS,":[199],"30.7":[200],"vs.":[201],"15.4":[202],"months;":[203],"hazard":[204],"ratio":[205],"0.512;":[207],"P":[208],"=.003),":[209],"similar":[211],"findings":[212],"propensity":[214],"score":[215],"adjustment.":[216],"improvement":[219],"past":[227],"decade":[228],"be":[230],"attributable":[231],"shorter":[233],"earlier":[239],"transitions":[240],"next-line":[242],"therapies":[243],"clinical":[245,256],"trials.":[246],"Evolving":[247],"are":[250],"key":[251],"considerations":[252],"when":[253],"interpreting":[254],"future":[255],"trial":[257],"outcomes.":[258],"Trial":[259],"registration":[260],"ClinicalTrials.gov,":[261],"NCT02426086":[262],"April":[263],"21,":[264],"2015.":[265]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-11-12T00:00:00"}